Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: A cross-sectional study

Heart

Volumn 93, Issue 10, 2007, Pages 1256-1262

  Hippisley Cox, Julia ^a   Parker, Chris ^b   Coupland, Carol ^a   Vinogradova, Yana ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Nottingham Primary Care Research Partnership   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; FEMALE; GENERAL PRACTICE; HEALTH CARE DELIVERY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING CESSATION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MENTAL DISORDERS; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTORS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS;

EID: 34848852679     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.110171     Document Type: Article

References (32)

1. World Health Organisation. World health report. Geneva: WHO, 2004.
2. National Institute for Clinical Excellence. Statins for the prevention of coronary events: draft guidance. London: NICE, 2005.
3. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344: 1383-9.
4. Long-term Intervention with Pravastatin in Ischaemic Heart Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
5. Hippisley-Cox J, Coupland C. The effect of statins on mortality in patients with ischaemic heart disease: population-based cohort study with case control analysis. Heart 2005:61523.
6. The NHS Confederation. The new GMS contract. London: The NHS Confederation, 2003:108.
7. Hippisley-Cox J, Pringle M. Health inequalities experienced by people with schizophrenia and manic depression: analysis of general practice data in England and Wales, Report to the Disability Rights Commission. University of Nottingham, Nottingham, UK: Disability Rights Commission, 2005.
8. Harris SC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998;173:11-53.
9. Dembling BP, Chen DT, Vachon L. Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv 1999;50:1036-42.
10. Tsuang MT, Woolson RF, Fleming JA. Premature deaths in schizophrenia and affective disorders. Arch Gen Psychiatry 1980;37:979-83.
11. Seymour L. Not all in the mind. The physical health of mental health service users. Radical mentalities - briefing paper 2. London: Mentality, 2003.
12. Brown S, Birtwistle J, Roe L, et al. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29:697- 701.
13. Burns T, Cohen A. Item of service payments for general practitioner care of severely mentally ill patients: does the money matter? Br J Gen Pract 1998;48:1415-6.
14. Druss BG, Bradford DW, Rosenheck RA, et al. Mental disorders and use of cardiovascular procedures after myocardial infarction[see comment]. JAMA 2000;283:506-11.
15. Druss BG, Bradford WD, Rosenheck RA, et al. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 2001;58:565-72.
16. Petersen LA, Normand S-LT, Druss BG, et al. Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? Health Serv Res 2003;38(Pt 1):41-63.
17. Desai MM, Rosenheck RA, Druss BG, et al. Mental disorders and quality of care among postacute myocardial infarction outpatients. J Nerv Ment Dis 2002;190:51-3.
18. Hippisley-Cox J, Vinogradova Y, Coupland C, et al. Comparison of key practice characteristics between general practices in England and Wales and general practices in the QRESEARCH data, Report to the Health and Social Care Information Centre. University of Nottingham, Nottingham, UK: Health and Social Care Information Centre, 2005.
19. Office for National Statistics. Key health statistics in general practice. London: Office of National Statistics, 1998.
20. Hippisley-Cox J, Pringle M. Prevalence, care and outcomes for patients with diet controlled diabetes in general practice: cross sectional survey. Lancet 2004;364:423-8.
21. Hammersley V, Hippisley-Cox J, Wilson A, et al. A comparison of research General Practices and their patients with other practices - cross sectional survey in Trent. Br J Gen Pract 2002;52:463-8.
22. PRIMIS+. Severe mental illness statistics. University of Nottingham, Nottingham, UK, 2006 http://www.primis.nhs.uk (accessed 3 Mar 2007).
23. McNutt L-A, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003;157:940-3.
24. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986;1:54-77.
25. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
26. Hippisley-Cox J, Pringle M, Cater R, et al. The electronic record in primary care - regression or progression? Cross-sectional survey. BMJ 2003;326:1439-43.
27. Ryan MC, Thakore JH. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci 2002;71:239-57.
28. Witchel HJ, Hancox JC, Nutt DJ. Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol 2003;23:58- 77.
29. Henderson DC, Ettinger EP. Glucose intolerance and diabetes in schizophrenia,. In: Meyer JM, Nasrallah HA, eds. Medical Illness and Schizophrenia. Washington DC: American Psychiatric Publishing, 2003:99-114.
30. Sernyak MJ, Leslie DL, Alarcon RD, et al. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002;159:561-6.
31. Osborn DPJ, King MB, Nazareth I. Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice. BMJ 2003;326:1122-3.
32. Osborn DPJ, Nazareth I, King MB. Risk for coronary heart disease in people with severe mental illness: cross-sectional comparative study in primary care. Br J Psychiatry 2006;188:271-7.